glp1 sema cagrilintide The expanding landscape of GLP-1 medicines Cagrilintide 10mg, Semaglutide 10mg Blend
Description
Obesity increases the risk of IBD flare-ups and symptoms like pain and fatigue
Your stomach holds food longer before releasing it into your small intestine
Genetic susceptibility further complicates the picture
- :
Furthermore, the current codes are stigmatizing and reflect outdated scientific understanding of the disease processes underlying obesity
PMID: 29487568
